Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record now indicates that results have been posted and includes updated completion dates and related study documents, reflecting the PATHWay trial's final data availability. This update communicates the trial's progression to results reporting and final status to users reviewing the record.
    Difference
    3%
    Check dated 2026-05-15T06:01:18.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision/version has been incremented from v3.5.2 to v3.5.3, indicating a backend or release update without altering the displayed study information.
    Difference
    0.1%
    Check dated 2026-04-24T04:12:15.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:08:45.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Site revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:28:49.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to study content.
    Difference
    0.1%
    Check dated 2026-03-11T16:49:10.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.4.2', and the prior general funding/operating status notice was removed. These are administrative changes that do not affect the study content, eligibility criteria, or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T01:20:58.000Z thumbnail image

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.